VeriMomVeriMom
HIGH RISK

Hamilelikte sodium oxymethylene sulfoxylate kullanmaktan kaçınmalı mıyım? | VeriMom

Reviewed by · Last reviewed

ECHA regulatory hazard statements

  • H361

Products containing sodium oxymethylene sulfoxylate — check your shelf

These products list sodium oxymethylene sulfoxylate on their INCI. If one is in your routine, consider swapping it during pregnancy.

What to use instead

Pregnancy-safe ingredients that serve a similar function:

Pregnancy-safe products to use instead

Products built around the safer ingredients above, scored "no known risks" or "low risk".

Sources & references

Authoritative references used to score this ingredient.

Hamilelikte sodium oxymethylene sulfoxylate yerine kullanılabilecek güvenli alternatifler | VeriMom

İçeriklerİçerikler

Ayrıca bakın

FAQ

sodium oxymethylene sulfoxylate hamilelikte güvenli mi?
No EU harmonised CMR classification or cosmetic Annex II/III listing was found for CAS 149-44-0 (ECHA InfoCard and registration page). Multiple supplier SDSs and product pages report industry classifications of GMM Cat 2 / Repr Cat 2 (H341/H361) but these appear to be company/notification classifications rather than an EU-harmonised CLP entry. There are no peer-reviewed animal reproductive/developmental studies located on PubMed for the substance. The main mechanism of concern is theoretical: the substance can decompose in acid to release formaldehyde (a known CMR), providing a structural/derivative-based alert; therefore hazard is scored 1, mechanism 1. Topical cosmetic exposure is expected to be low but measurable (score 1). Sources: ECHA substance page, supplier/SDS documents (Sigma, TCI), product ingredient listings showing cosmetic use.
sodium oxymethylene sulfoxylate emzirirken güvenli mi?
Same rationale as pregnancy: no harmonised classification nor published reproductive studies specifically showing transfer into breastmilk; theoretical concern derives from possible release of formaldehyde on decomposition which could increase hazard if significant release/absorption occurred. For typical topical cosmetic use exposure is low but measurable, so h=1, m=1, e=1.
sodium oxymethylene sulfoxylate bebek cildi için güvenli mi?
Hazard and mechanism follow the adult evaluation (no direct infant-specific data). Because infant skin has higher absorption / immature barrier, exposure score is increased by +1 (from 1 to 2) per your instructions. There are no infant-specific toxicity studies. Theoretical concern remains the potential for decomposition to formaldehyde under acidic conditions; no evidence that cosmetic use leads to meaningful formaldehyde release in-use was found.
VeriMom sodium oxymethylene sulfoxylate nasıl puanlıyor?
VeriMom sodium oxymethylene sulfoxylate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
Hamilelikte sodium oxymethylene sulfoxylate yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin